News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
58,672 Results
Type
Article (3741)
Company Profile (10)
Press Release (54921)
Multimedia
Podcasts (9)
Webinars (6)
Section
Business (21532)
Career Advice (67)
Deals (3791)
Drug Delivery (13)
Drug Development (4145)
Employer Resources (12)
FDA (836)
Job Trends (1073)
News (29225)
Policy (1316)
Tag
Academia (240)
Accelerated approval (1)
Allergies (7)
Alliances (5178)
ALS (11)
Alzheimer's disease (140)
Antibody-drug conjugate (ADC) (17)
Approvals (850)
Artificial intelligence (84)
Autoimmune disease (21)
Automation (2)
Bankruptcy (31)
Best Places to Work (750)
BIOSECURE Act (2)
Biosimilars (22)
Biotechnology (13)
Bladder cancer (6)
Brain cancer (3)
Breast cancer (24)
Cancer (258)
Cardiovascular disease (39)
Career advice (61)
Career pathing (3)
CAR-T (26)
Cell therapy (67)
Clinical research (3352)
Collaboration (180)
Compensation (8)
Complete response letters (4)
COVID-19 (158)
CRISPR (10)
C-suite (150)
Cystic fibrosis (15)
Data (304)
Denatured (3)
Depression (8)
Diabetes (29)
Diagnostics (597)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (2)
Drug discovery (36)
Drug pricing (14)
Duchenne muscular dystrophy (7)
Earnings (4506)
Editorial (7)
Employer resources (10)
Events (5447)
Executive appointments (179)
FDA (1017)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (675)
Gene editing (22)
Generative AI (8)
Gene therapy (53)
GLP-1 (75)
Government (135)
Guidances (27)
Healthcare (1263)
HIV (4)
Huntington's disease (1)
IgA nephropathy (11)
Immunology and inflammation (28)
Immuno-oncology (3)
Indications (5)
Infectious disease (174)
Inflammatory bowel disease (17)
Inflation Reduction Act (4)
Influenza (4)
Intellectual property (18)
Interviews (5)
IPO (1782)
IRA (8)
Job creations (318)
Job search strategy (57)
JPM (10)
Labor market (17)
Layoffs (42)
Leadership (3)
Legal (275)
Liver cancer (4)
Longevity (2)
Lung cancer (32)
Lymphoma (19)
Machine learning (7)
Management (4)
Manufacturing (64)
MASH (14)
Medical device (1329)
Medtech (1339)
Mergers & acquisitions (2126)
Metabolic disorders (97)
Multiple sclerosis (4)
NASH (2)
Neurodegenerative disease (31)
Neuropsychiatric disorders (7)
Neuroscience (223)
Neurotech (1)
NextGen: Class of 2026 (964)
Non-profit (292)
Now hiring (3)
Obesity (54)
Opinion (52)
Ovarian cancer (7)
Pain (12)
Pancreatic cancer (4)
Parkinson's disease (19)
Partnered (7)
Patents (21)
Patient recruitment (51)
Peanut (5)
People (9049)
Pharmaceutical (4)
Phase 1 (1142)
Phase 2 (1548)
Phase 3 (929)
Pipeline (287)
Policy (19)
Postmarket research (95)
Preclinical (617)
Press Release (6)
Prostate cancer (16)
Psychedelics (4)
Radiopharmaceuticals (31)
Rare diseases (66)
Real estate (585)
Recruiting (5)
Regulatory (1099)
Reports (4)
Research institute (173)
Resumes & cover letters (9)
Rett syndrome (2)
RNA editing (2)
Schizophrenia (5)
Series A (184)
Series B (137)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (2204)
Supply chain (5)
Tariffs (4)
The Weekly (6)
Vaccines (32)
Venture capital (79)
Weight loss (28)
Women's health (6)
Date
Last 7 days (37)
Last 30 days (159)
Last 365 days (2348)
2026 (222)
2025 (2454)
2024 (2931)
2023 (3113)
2022 (5523)
2021 (4858)
2020 (4673)
2019 (4313)
2018 (3461)
2017 (3046)
2016 (2526)
2015 (2923)
2014 (2099)
2013 (1739)
2012 (1852)
2011 (2067)
2010 (2170)
Location
Africa (68)
Alabama (7)
Alaska (2)
Arizona (17)
Arkansas (5)
Asia (4107)
Australia (497)
California (877)
Canada (733)
China (87)
Colorado (23)
Connecticut (35)
Delaware (11)
Europe (8662)
Florida (66)
Georgia (30)
Hawaii (2)
Idaho (5)
Illinois (55)
India (15)
Indiana (27)
Iowa (2)
Japan (43)
Kansas (7)
Kentucky (5)
Louisiana (6)
Maine (6)
Maryland (63)
Massachusetts (516)
Michigan (17)
Minnesota (26)
Mississippi (1)
Missouri (16)
Montana (1)
Nebraska (1)
Nevada (14)
New Hampshire (7)
New Jersey (139)
New Mexico (4)
New York (181)
North Carolina (106)
Northern California (414)
Ohio (37)
Oklahoma (4)
Oregon (4)
Pennsylvania (96)
Puerto Rico (3)
Rhode Island (6)
South America (99)
South Carolina (7)
Southern California (317)
Tennessee (11)
Texas (87)
United States (2503)
Utah (32)
Virginia (17)
Washington D.C. (2)
Washington State (51)
West Virginia (1)
Wisconsin (12)
58,672 Results for "sofinnova ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apnimed to Participate in the LifeSci Capital & Sofinnova Partners Growth and Innovation Summit
November 11, 2025
·
1 min read
Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner
Sofinnova Partners announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign, has joined Sofinnova as an advisory Venture Partner.
January 4, 2024
·
3 min read
Insights
From Nuclear Winter to Renewal: Biotech Investing for 2026
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Maha Katabi, general partner at Sofinnova Investments and Andrew Lam, managing director, head of Biotech Private Equity at Ally Bridge Group, about how M &A dynamics, dealmaking and global partnerships are reshaping portfolio valuations and paths to growth in 2026.
January 8, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Forth Tx Launches With Backing From Sofinnova Partners to Revolutionize Fibrosis Treatments
March 18, 2025
·
3 min read
Press Releases
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
March 18, 2025
·
4 min read
Press Releases
BioClec Launches With Backing From Sofinnova Partners to Pioneer Breakthrough Alzheimer’s Therapies
March 18, 2025
·
2 min read
Press Releases
Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation
March 4, 2025
·
3 min read
Press Releases
Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
March 18, 2025
·
3 min read
Business
Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the strategic strengthening of its medtech acceleration team with the appointment of Mano Iyer as Partner and the promotion of Cécile Dupont to Partner.
November 13, 2023
·
3 min read
Press Releases
RAD Increases Ownership in Radiopharm Ventures to 87.5%
January 12, 2026
·
3 min read
1 of 5,868
Next
